Caliber Wealth Management (Utah)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.34M Sell
26,856
-189
-0.7% -$16.1K 1.24% 37
2023
Q4
$2.23M Buy
27,045
+1,378
+5% +$105K 1.31% 33
2023
Q3
$2.01M Buy
25,667
+2,477
+11% +$207K 1.35% 36
2023
Q2
$2.04M Buy
23,190
+1,600
+7% +$138K 1.37% 35
2023
Q1
$1.74M Buy
21,590
+293
+1% +$23.9K 1.3% 37
2022
Q4
$1.66M Buy
21,297
+10,900
+105% +$883K 1.27% 34
2022
Q3
$840K Buy
10,397
+637
+7% +$57.2K 0.66% 50
2022
Q2
$876K Buy
+9,760
New +$989K 0.68% 49

Other funds holding MDT

Caliber Wealth Management (Utah)'s MDT Position: Q1 2024 in Review

Caliber Wealth Management (Utah) reduced its Medtronic (MDT) stake by 0.7% in Q1 2024, selling an estimated $16.1K and leaving 26,856 shares worth $2.34M. The position accounts for 1.24% of the portfolio, ranked #37.

Caliber Wealth Management (Utah) first reported a position in MDT in Q2 2022 and has held it in 8 quarters since. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Caliber Wealth Management (Utah) held 26,856 shares of Medtronic worth $2.34M as of Q1 2024.
  • Caliber Wealth Management (Utah) sold 189 Medtronic shares in Q1 2024, an estimated $16.1K.
  • Medtronic made up 1.24% of Caliber Wealth Management (Utah)'s portfolio in Q1 2024, its #37 holding.
  • Caliber Wealth Management (Utah) first reported a position in Medtronic in Q2 2022 and has held it in 8 quarters since.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Caliber Wealth Management (Utah)'s 13F filing for Q1 2024, filed 25 Apr 2024.